The impact will go beyond Roche’s US unit, called Genentech, to affect the Swiss drugmaker’s business worldwide, management told workers late Tuesday in an email that was seen by Bloomberg News.
“Many of you may wonder why changes in US law may require adjustments at the global level, rather than just within our US entities,” Roche said in the staff email. “It is because our global programs and goals ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.